Skip to content
Saturday, November 14, 2026
Explore the latest technology trends, gadget reviews, and i…

Patients Stopping Anti-Obesity Jabs Gain Back Pounds Far More Rapidly Than Dieters

Image of medical injection and weighing machine
Weight management involves long-term strategies.

Fresh analysis indicates that individuals who discontinue popular weight-loss injections like Wegovy and Mounjaro may regain lost weight at a significantly accelerated pace than those who end conventional lifestyle regimens.

Findings released in a leading medical journal points out that while overweight people can lose about a fifth of their total mass while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month after stopping.

"Users buying such treatments must be cognizant of the danger of rapid rebound weight gain when the medication ends," cautioned lead investigator Dr. Susan Jebb.

This pace of recovery means a reversion to pre-treatment mass in about one and a half years.

Comparing Treatments

The analysis, which looked at 37 of trials involving thousands of patients, compared the outcomes of these new drugs with conventional dieting.

Scientists point out that individuals who lose weight through diet and exercise generally experience a more gradual creep back—approximately 0.1 kg a month—post-intervention.

Explaining the Rapid Regain

Experts propose the way of the injections explains the accelerated weight return.

These medications mimic a natural hormone called GLP-1, which moderates feelings of fullness.

"Long-term administration of the hormone levels far above than normal might result in the body to generate a reduced amount of its endogenous hormone, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.

"Discontinuation of this GLP-1 'fix' leads to appetite is uncontrolled, making excessive eating much more probable."

A Chronic Disease?

Medical guidelines advise the injections for individuals with weight-linked medical conditions, alongside recommended diet and exercise modifications.

A number of clinicians argue that, given the significant potential of relapse, the therapy is often life-long.

This perspective is reinforced by pharmaceutical companies, who say that the findings "highlight the chronic nature of excess weight," similar to managing conditions like high blood pressure.

Patient Testimonies

People who have come off the medication describe a intense return of appetite.

"I experienced a switch that goes on and you become starving," recalled an individual.

This challenge is exacerbated if patients have not developed permanent lifestyle or habit modifications during treatment.

Widespread Use

Survey data show that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with interest continuing to grow.

  • Use is more common among women compared to males.
  • The middle-aged demographic shows the greatest level of interest.
  • A large proportion obtain the medications through private healthcare rather than the NHS.

In conclusion, experts stress that while GLP-1 drugs are potent tools for weight loss, they are not a permanent cure and lasting health benefits hinges on combined lifestyle support.

BC
The writer

Becky Campbell

A tech journalist and innovation enthusiast with over a decade of experience covering emerging technologies and digital trends.

Bright Club Base

Type to search articles.